Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|
Revenue From Operations | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 |
Sale of Products | 19,325.30 | 16,338.00 | 13,921.20 | 13,236.40 |
Sale of Services | 127.70 | 600.20 | 428.90 | 72.00 |
Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|
Fixed Assets | 10,493.90 | 9,274.00 | 8,135.30 | 8,816.90 |
Property, Plant and Equipments | 6,248.70 | 5,654.20 | 4,886.90 | 4,732.20 |
Right-of-Use Assets | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 4,176.90 | 3,564.90 | 3,234.60 | 3,473.50 |
Market Cap (Rs in Crs) | 99,705.32 | |
---|---|---|
P/E | 19.24 | |
Book Value (Rs) | 322.47 | |
Div (%) | 800 | |
Market Lot | 1 |
EPS (TTM) | 62.12 | |
---|---|---|
Price/Book | 3.71 | |
Div Yield.(%) | 0.67 | |
Face value (RS) | 1 | |
Deliverables (%) | 41.98 |
Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
---|---|---|---|---|---|
Sun Pharmaceuti... | 4,18,743.94 | 1,757.40 | 1,745.25 | 0.70 | 1,960.20 - 1,367.75 |
Divis Laborator... | 1,52,209.07 | 5,611.00 | 5,733.60 | -2.14 | 6,448.75 - 3,350.05 |
Cipla Ltd | 1,17,762.24 | 1,455.40 | 1,458.15 | -0.19 | 1,702.00 - 1,312.70 |
Torrent Pharmac... | 1,13,616.11 | 3,316.95 | 3,357.15 | -1.20 | 3,589.95 - 2,460.05 |
Mankind Pharma ... | 1,02,663.15 | 2,457.65 | 2,488.40 | -1.24 | 3,050.00 - 1,910.10 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
Category | No. of Shares | Percentage |
---|---|---|
Total Foreign | 23,24,90,593 | 27.86 |
Total Institutions | 30,15,11,524 | 36.13 |
Total Govt Holding | 0 | 0.00 |
Total Non Promoter Corporate Holding | 30,56,839 | 0.37 |
Total Promoters | 22,23,05,640 | 26.64 |
Total Public & others | 75059364 | 8.99 |
Total | 83,44,23,960 | 100 |